ACE2 as Drug Target of COVID-19 Virus Treatment, Simplified Updated Review.

ABSTRACT:

Background

Since its first appearance in December of 2019, regular updates around the world demonstrates that the number of new Corona Virus 2019 (COVID-19) cases are increasing rapidly, indicating that not only does COVID-19 exhibit a rapid spread pattern, but human intervention is necessary for its resolution. Up until today (27-5-2020) and according to the World Health Organization (WHO), the number of confirmed COVID-19 cases has surpassed 4.5 million with more than 307, 500 deaths. Almost all countries have been affected by COVID-19, and resultingly, various drug trials have been conducted, however, a targeted treatment remains to be made accessible to the public. Recently, Angiotensin-Converting Enzyme-2 (ACE2) has gained some attention for its discovery as a potential attach

SUBMITTER: Mostafa-Hedeab G 

PROVIDER: S-EPMC7424417 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature